Larvol Delta - Avalo-Announces-Topline-Data-from-Phase-2-PEAK-Trial-for-AVTX002-quisovalimab-in-Patients-with-NonEosinophilic-Asthma

quisovalimab (AVTX-002) - Kyowa Kirin, Sanofi, Avalo Therap

https://www.globenewswire.com/news-release/2023/06/26/2694293/0/en/Avalo-Announces-Topline-Data-from-Phase-2-PEAK-Trial-for-AVTX-002-quisovalimab-in-Patients-with-Non-Eosinophilic-Asthma.html

Jun 26, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next